An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably
- Autores
- Emanuel, Ezekiel J.; Persad, Govind; Kern, Adam; Buchanan, Allen; Fabre, Cécile; Halliday, Daniel; Heath, Joseph; Herzog, Lisa; Leland, R. J.; Lemango, Ephrem T.; Luna, Florencia; McCoy, Matthew S.; Norheim, Ole F.; Ottersen, Trygve; Schaefer, G. Owen; Tan, Kok-Chor; Wellman, Christopher Heath; Wolff, Jonathan; Richardson, Henry S.
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Once effective coronavirus disease 2019 (COVID-19) vaccines are developed, they will be scarce. This presents the question of how to distribute them fairly across countries. Vaccine allocation among countries raises complex and controversial issues involving public opinion, diplomacy, economics, public health, and other considerations. Nevertheless, many national leaders, international organizations, and vaccine producers recognize that one central factor in this decision-making is ethics (1, 2). Yet little progress has been made toward delineating what constitutes fair international distribution of vaccine. Many have endorsed ?equitable distribution of COVID-19?vaccine? without describing a framework or recommendations (3, 4). Two substantive proposals for the international allocation of a COVID-19 vaccine have been advanced, but are seriously flawed. We offer a more ethically defensible and practical proposal for the fair distribution of COVID-19 vaccine: the Fair Priority Model.The Fair Priority Model is primarily addressed to three groups. One is the COVAX facility?led by Gavi, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations (CEPI)?which intends to purchase vaccines for fair distribution across countries (5). A second group is vaccine producers. Thankfully, many producers have publicly committed to a ?broad and equitable? international distribution of vaccine (2). The last group is national governments, some of whom have also publicly committed to a fair distribution (1).These groups need a clear framework for reconciling competing values, one that they and others will rightly accept as ethical and not just as an assertion of power. The Fair Priority Model specifies what a fair distribution of vaccines entails, giving content to their commitments. Moreover, acceptance of this common ethical framework will reduce duplication and waste, easing efforts at a fair distribution. That, in turn, will enhance producers' confidence that vaccines will be fairly allocated to benefit people, thereby motivating an increase in vaccine supply for international distribution.
Fil: Emanuel, Ezekiel J.. University of Pennsylvania; Estados Unidos
Fil: Persad, Govind. University of Denver.; Estados Unidos
Fil: Kern, Adam. University of Princeton; Estados Unidos
Fil: Buchanan, Allen. University of Arizona; Estados Unidos
Fil: Fabre, Cécile. All Souls College; Reino Unido
Fil: Halliday, Daniel. University of Melbourne; Australia
Fil: Heath, Joseph. University of Toronto; Canadá
Fil: Herzog, Lisa. University of Groningen; Países Bajos
Fil: Leland, R. J.. University of Manitoba; Canadá
Fil: Lemango, Ephrem T.. No especifíca;
Fil: Luna, Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Facultad Latinoamericana de Ciencias Sociales; Argentina
Fil: McCoy, Matthew S.. University of Pennsylvania; Estados Unidos
Fil: Norheim, Ole F.. University of Bergen; Noruega
Fil: Ottersen, Trygve. Norwegian Institute Of Public Health; Noruega
Fil: Schaefer, G. Owen. Yong Loo Lin School Of Medicine; Singapur
Fil: Tan, Kok-Chor. University of Pennsylvania; Estados Unidos
Fil: Wellman, Christopher Heath. Washington University in St. Louis; Estados Unidos
Fil: Wolff, Jonathan. University of Oxford; Reino Unido
Fil: Richardson, Henry S.. Kennedy Institute Of Ethics; Estados Unidos - Materia
-
COVID-19
VACCINE
DISTRIBUTION
EQUITY - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/145501
Ver los metadatos del registro completo
id |
CONICETDig_2213545b81d70392b55de49bbca3488f |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/145501 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitablyEmanuel, Ezekiel J.Persad, GovindKern, AdamBuchanan, AllenFabre, CécileHalliday, DanielHeath, JosephHerzog, LisaLeland, R. J.Lemango, Ephrem T.Luna, FlorenciaMcCoy, Matthew S.Norheim, Ole F.Ottersen, TrygveSchaefer, G. OwenTan, Kok-ChorWellman, Christopher HeathWolff, JonathanRichardson, Henry S.COVID-19VACCINEDISTRIBUTIONEQUITYhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Once effective coronavirus disease 2019 (COVID-19) vaccines are developed, they will be scarce. This presents the question of how to distribute them fairly across countries. Vaccine allocation among countries raises complex and controversial issues involving public opinion, diplomacy, economics, public health, and other considerations. Nevertheless, many national leaders, international organizations, and vaccine producers recognize that one central factor in this decision-making is ethics (1, 2). Yet little progress has been made toward delineating what constitutes fair international distribution of vaccine. Many have endorsed ?equitable distribution of COVID-19?vaccine? without describing a framework or recommendations (3, 4). Two substantive proposals for the international allocation of a COVID-19 vaccine have been advanced, but are seriously flawed. We offer a more ethically defensible and practical proposal for the fair distribution of COVID-19 vaccine: the Fair Priority Model.The Fair Priority Model is primarily addressed to three groups. One is the COVAX facility?led by Gavi, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations (CEPI)?which intends to purchase vaccines for fair distribution across countries (5). A second group is vaccine producers. Thankfully, many producers have publicly committed to a ?broad and equitable? international distribution of vaccine (2). The last group is national governments, some of whom have also publicly committed to a fair distribution (1).These groups need a clear framework for reconciling competing values, one that they and others will rightly accept as ethical and not just as an assertion of power. The Fair Priority Model specifies what a fair distribution of vaccines entails, giving content to their commitments. Moreover, acceptance of this common ethical framework will reduce duplication and waste, easing efforts at a fair distribution. That, in turn, will enhance producers' confidence that vaccines will be fairly allocated to benefit people, thereby motivating an increase in vaccine supply for international distribution.Fil: Emanuel, Ezekiel J.. University of Pennsylvania; Estados UnidosFil: Persad, Govind. University of Denver.; Estados UnidosFil: Kern, Adam. University of Princeton; Estados UnidosFil: Buchanan, Allen. University of Arizona; Estados UnidosFil: Fabre, Cécile. All Souls College; Reino UnidoFil: Halliday, Daniel. University of Melbourne; AustraliaFil: Heath, Joseph. University of Toronto; CanadáFil: Herzog, Lisa. University of Groningen; Países BajosFil: Leland, R. J.. University of Manitoba; CanadáFil: Lemango, Ephrem T.. No especifíca;Fil: Luna, Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Facultad Latinoamericana de Ciencias Sociales; ArgentinaFil: McCoy, Matthew S.. University of Pennsylvania; Estados UnidosFil: Norheim, Ole F.. University of Bergen; NoruegaFil: Ottersen, Trygve. Norwegian Institute Of Public Health; NoruegaFil: Schaefer, G. Owen. Yong Loo Lin School Of Medicine; SingapurFil: Tan, Kok-Chor. University of Pennsylvania; Estados UnidosFil: Wellman, Christopher Heath. Washington University in St. Louis; Estados UnidosFil: Wolff, Jonathan. University of Oxford; Reino UnidoFil: Richardson, Henry S.. Kennedy Institute Of Ethics; Estados UnidosAmerican Association for the Advancement of Science2020-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/145501Emanuel, Ezekiel J.; Persad, Govind; Kern, Adam; Buchanan, Allen; Fabre, Cécile; et al.; An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably; American Association for the Advancement of Science; Science; 369; 6509; 9-2020; 1309-13120036-8075CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://science.sciencemag.org/content/369/6509/1309info:eu-repo/semantics/altIdentifier/doi/10.1126/SCIENCE.ABE2803info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:34:09Zoai:ri.conicet.gov.ar:11336/145501instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:34:09.979CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably |
title |
An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably |
spellingShingle |
An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably Emanuel, Ezekiel J. COVID-19 VACCINE DISTRIBUTION EQUITY |
title_short |
An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably |
title_full |
An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably |
title_fullStr |
An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably |
title_full_unstemmed |
An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably |
title_sort |
An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably |
dc.creator.none.fl_str_mv |
Emanuel, Ezekiel J. Persad, Govind Kern, Adam Buchanan, Allen Fabre, Cécile Halliday, Daniel Heath, Joseph Herzog, Lisa Leland, R. J. Lemango, Ephrem T. Luna, Florencia McCoy, Matthew S. Norheim, Ole F. Ottersen, Trygve Schaefer, G. Owen Tan, Kok-Chor Wellman, Christopher Heath Wolff, Jonathan Richardson, Henry S. |
author |
Emanuel, Ezekiel J. |
author_facet |
Emanuel, Ezekiel J. Persad, Govind Kern, Adam Buchanan, Allen Fabre, Cécile Halliday, Daniel Heath, Joseph Herzog, Lisa Leland, R. J. Lemango, Ephrem T. Luna, Florencia McCoy, Matthew S. Norheim, Ole F. Ottersen, Trygve Schaefer, G. Owen Tan, Kok-Chor Wellman, Christopher Heath Wolff, Jonathan Richardson, Henry S. |
author_role |
author |
author2 |
Persad, Govind Kern, Adam Buchanan, Allen Fabre, Cécile Halliday, Daniel Heath, Joseph Herzog, Lisa Leland, R. J. Lemango, Ephrem T. Luna, Florencia McCoy, Matthew S. Norheim, Ole F. Ottersen, Trygve Schaefer, G. Owen Tan, Kok-Chor Wellman, Christopher Heath Wolff, Jonathan Richardson, Henry S. |
author2_role |
author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
COVID-19 VACCINE DISTRIBUTION EQUITY |
topic |
COVID-19 VACCINE DISTRIBUTION EQUITY |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Once effective coronavirus disease 2019 (COVID-19) vaccines are developed, they will be scarce. This presents the question of how to distribute them fairly across countries. Vaccine allocation among countries raises complex and controversial issues involving public opinion, diplomacy, economics, public health, and other considerations. Nevertheless, many national leaders, international organizations, and vaccine producers recognize that one central factor in this decision-making is ethics (1, 2). Yet little progress has been made toward delineating what constitutes fair international distribution of vaccine. Many have endorsed ?equitable distribution of COVID-19?vaccine? without describing a framework or recommendations (3, 4). Two substantive proposals for the international allocation of a COVID-19 vaccine have been advanced, but are seriously flawed. We offer a more ethically defensible and practical proposal for the fair distribution of COVID-19 vaccine: the Fair Priority Model.The Fair Priority Model is primarily addressed to three groups. One is the COVAX facility?led by Gavi, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations (CEPI)?which intends to purchase vaccines for fair distribution across countries (5). A second group is vaccine producers. Thankfully, many producers have publicly committed to a ?broad and equitable? international distribution of vaccine (2). The last group is national governments, some of whom have also publicly committed to a fair distribution (1).These groups need a clear framework for reconciling competing values, one that they and others will rightly accept as ethical and not just as an assertion of power. The Fair Priority Model specifies what a fair distribution of vaccines entails, giving content to their commitments. Moreover, acceptance of this common ethical framework will reduce duplication and waste, easing efforts at a fair distribution. That, in turn, will enhance producers' confidence that vaccines will be fairly allocated to benefit people, thereby motivating an increase in vaccine supply for international distribution. Fil: Emanuel, Ezekiel J.. University of Pennsylvania; Estados Unidos Fil: Persad, Govind. University of Denver.; Estados Unidos Fil: Kern, Adam. University of Princeton; Estados Unidos Fil: Buchanan, Allen. University of Arizona; Estados Unidos Fil: Fabre, Cécile. All Souls College; Reino Unido Fil: Halliday, Daniel. University of Melbourne; Australia Fil: Heath, Joseph. University of Toronto; Canadá Fil: Herzog, Lisa. University of Groningen; Países Bajos Fil: Leland, R. J.. University of Manitoba; Canadá Fil: Lemango, Ephrem T.. No especifíca; Fil: Luna, Florencia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Facultad Latinoamericana de Ciencias Sociales; Argentina Fil: McCoy, Matthew S.. University of Pennsylvania; Estados Unidos Fil: Norheim, Ole F.. University of Bergen; Noruega Fil: Ottersen, Trygve. Norwegian Institute Of Public Health; Noruega Fil: Schaefer, G. Owen. Yong Loo Lin School Of Medicine; Singapur Fil: Tan, Kok-Chor. University of Pennsylvania; Estados Unidos Fil: Wellman, Christopher Heath. Washington University in St. Louis; Estados Unidos Fil: Wolff, Jonathan. University of Oxford; Reino Unido Fil: Richardson, Henry S.. Kennedy Institute Of Ethics; Estados Unidos |
description |
Once effective coronavirus disease 2019 (COVID-19) vaccines are developed, they will be scarce. This presents the question of how to distribute them fairly across countries. Vaccine allocation among countries raises complex and controversial issues involving public opinion, diplomacy, economics, public health, and other considerations. Nevertheless, many national leaders, international organizations, and vaccine producers recognize that one central factor in this decision-making is ethics (1, 2). Yet little progress has been made toward delineating what constitutes fair international distribution of vaccine. Many have endorsed ?equitable distribution of COVID-19?vaccine? without describing a framework or recommendations (3, 4). Two substantive proposals for the international allocation of a COVID-19 vaccine have been advanced, but are seriously flawed. We offer a more ethically defensible and practical proposal for the fair distribution of COVID-19 vaccine: the Fair Priority Model.The Fair Priority Model is primarily addressed to three groups. One is the COVAX facility?led by Gavi, the World Health Organization (WHO), and the Coalition for Epidemic Preparedness Innovations (CEPI)?which intends to purchase vaccines for fair distribution across countries (5). A second group is vaccine producers. Thankfully, many producers have publicly committed to a ?broad and equitable? international distribution of vaccine (2). The last group is national governments, some of whom have also publicly committed to a fair distribution (1).These groups need a clear framework for reconciling competing values, one that they and others will rightly accept as ethical and not just as an assertion of power. The Fair Priority Model specifies what a fair distribution of vaccines entails, giving content to their commitments. Moreover, acceptance of this common ethical framework will reduce duplication and waste, easing efforts at a fair distribution. That, in turn, will enhance producers' confidence that vaccines will be fairly allocated to benefit people, thereby motivating an increase in vaccine supply for international distribution. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/145501 Emanuel, Ezekiel J.; Persad, Govind; Kern, Adam; Buchanan, Allen; Fabre, Cécile; et al.; An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably; American Association for the Advancement of Science; Science; 369; 6509; 9-2020; 1309-1312 0036-8075 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/145501 |
identifier_str_mv |
Emanuel, Ezekiel J.; Persad, Govind; Kern, Adam; Buchanan, Allen; Fabre, Cécile; et al.; An ethical framework for global vaccine allocation: The Fair Priority Model offers a practical way to fulfill pledges to distribute vaccines fairly and equitably; American Association for the Advancement of Science; Science; 369; 6509; 9-2020; 1309-1312 0036-8075 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://science.sciencemag.org/content/369/6509/1309 info:eu-repo/semantics/altIdentifier/doi/10.1126/SCIENCE.ABE2803 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Association for the Advancement of Science |
publisher.none.fl_str_mv |
American Association for the Advancement of Science |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613055902646272 |
score |
13.070432 |